EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genetic Polymorphisms in Systemic Lupus Erythematosus and Their Clinical Implications: A Narrative Review

Audrey Matilda Egan iD, Nor Adzimah Johdi iD, Elena Aisha Azizan iD, Rozita Mohd, Sakthiswary Rajalingham, Syahrul Sazliyana Shaharir, Mohamed Afiq Hidayat Zailani iD

International Journal of Molecular Sciences · 29.04.2026 · 27 (9) · 3968

DOI: 10.3390/ijms27093968 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.04.2026. Verfasst von Audrey Matilda Egan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Cheras 56000, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Genetic Predisposition to Disease, Polymorphism, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a polygenic autoimmune disorder where genetic diversity drives significant clinical heterogeneity. This review summarizes the current understanding of the roles of genetic polymorphisms in immunological dysregulation, organ-specific manifestations and therapeutic response heterogeneity in individuals with SLE. The literature was obtained from PubMed, EBSCOhost, Web of Science and Scopus. The narrative review comprised 60 publications published within the last 12 years. The research consistently identifies the major histocompatibility complex (MHC) region as the most significant genetic risk factor for the onset of autoimmunity. Genetic variants in STAT4 and IRF5 exacerbate disease progression by facilitating chronic inflammation. These genetic factors are associated with various clinical outcomes, including renal and neuropsychiatric symptoms. Polymorphisms in HLA class II, TLR7 and FBN2 are notably linked to serious consequences, including lupus nephritis (LN). Progress in targeted therapy signifies a transition to personalized medicine with medications such as anifrolumab, litifilimab, iberdomide and Janus kinase (JAK) or Cyclin-Dependent Kinase (CDK) inhibitors, demonstrating potential for targeting pathways associated with the interferon gene signature and STAT4 polymorphisms. Notwithstanding the problems presented by the heterogeneity of SLE, the identification of risk variations is anticipated to enhance predictive and therapeutic biomarkers, hence facilitating more precise and individualized disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicGenetic Predisposition to DiseasePolymorphism, GeneticHumansInterferon Regulatory FactorsSTAT4 Transcription FactorToll-Like Receptor 7

Stichwörter der Autor:innen

autoimmune diseasebiomarkersgenetic polymorphismsmolecular geneticssingle nucleotide polymorphismsystemic lupus erythematosustargeted therapies

Substanzen

Interferon Regulatory FactorsSTAT4 Transcription FactorIRF5 protein, humanSTAT4 protein, humanToll-Like Receptor 7

Autor:innen und Institutionen

  • Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Cheras 56000, Kuala Lumpur, Malaysia.
  • UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Cheras 56000, Kuala Lumpur, Malaysia.
  • Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Cheras 56000, Kuala Lumpur, Malaysia.

ORCID-Profile: Audrey Matilda Egan, Nor Adzimah Johdi, Elena Aisha Azizan, Mohamed Afiq Hidayat Zailani

Förderung

  • Ministry of Higher Education Malaysia, Fundamental Research Grant Scheme (FRGS)

Zitieren

APA

Egan, A. M., Johdi, N. A., Azizan, E. A., Mohd, R., Rajalingham, S., Shaharir, S. S., & Zailani, M. A. H. (2026). Genetic Polymorphisms in Systemic Lupus Erythematosus and Their Clinical Implications: A Narrative Review. International Journal of Molecular Sciences, 27(9), 3968. https://doi.org/10.3390/ijms27093968

Vancouver

Egan AM, Johdi NA, Azizan EA, Mohd R, Rajalingham S, Shaharir SS, et al. Genetic Polymorphisms in Systemic Lupus Erythematosus and Their Clinical Implications: A Narrative Review. International Journal of Molecular Sciences. 2026;27(9):3968. doi:10.3390/ijms27093968

BibTeX
@article{Egan2026,
  author = {Egan, Audrey Matilda and Johdi, Nor Adzimah and Azizan, Elena Aisha and Mohd, Rozita and Rajalingham, Sakthiswary and Shaharir, Syahrul Sazliyana and Zailani, Mohamed Afiq Hidayat},
  title = {Genetic Polymorphisms in Systemic Lupus Erythematosus and Their Clinical Implications: A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3968},
  doi = {10.3390/ijms27093968}
}
Kostenlos starten →